BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38329526)

  • 1. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
    Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
    Geng B; Dilley M; Anterasian C
    Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study.
    Barroso B; Valverde-Monge M; Alobid I; Olaguibel JM; Rial MJ; Quirce S; Arismendi E; Barranco P; Betancor D; Bobolea I; Cárdaba B; Cruz Carmona MJ; Curto E; Domínguez-Ortega J; González-Barcala FJ; Martínez-Rivera C; Mahíllo-Fernández I; Muñoz X; Picado C; Plaza V; Rodrigo Muñoz JM; Soto-Retes L; Valero A; Del Pozo V; Mullol J; Sastre J
    J Investig Allergol Clin Immunol; 2023 Feb; 33(1):37-44. PubMed ID: 35416154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review.
    Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S
    Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
    Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
    Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-Life Experience of Biologic Treatment for Asthma on Chronic Rhinosinusitis: A Finnish Cohort.
    Lyly A; Genberg E; Kauppi P; Virkkula P; Lee SE; Laidlaw TM; Toppila-Salmi S; Lundberg M
    Int Arch Allergy Immunol; 2023; 184(2):149-160. PubMed ID: 36349770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
    Rivero A; Liang J
    Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):739-747. PubMed ID: 28918644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
    Al-Ahmad M; Ali A; Khalaf M; Alterki A; Rodriguez-Bouza T
    BMC Pulm Med; 2023 Jul; 23(1):266. PubMed ID: 37464395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.
    Brown WC; Senior B
    Curr Allergy Asthma Rep; 2020 Apr; 20(6):16. PubMed ID: 32323067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Webster KE; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013513. PubMed ID: 33710614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics in chronic rhinosinusitis with nasal polyposis.
    Laidlaw TM; Buchheit KM
    Ann Allergy Asthma Immunol; 2020 Apr; 124(4):326-332. PubMed ID: 31830587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics.
    Bartier S; Béquignon E; Thibaut de Ménonville C; Verillaud B; Evrard D; Léger M; Papon JF; Coste A; Taillé C
    J Asthma; 2023 Jan; 60(1):139-144. PubMed ID: 35073225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.